Yaz is the first oral contraceptive approved for premenstrual dysphoric disorder (PMDD)

Yaz is the first oral contraceptive approved for premenstrual dysphoric disorder (PMDD).

About 5% of reproductive age women have this more severe form of premenstrual syndrome.

Yaz seems to help both physical AND emotional symptoms.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote